EMV 0.00% $2.00 emvision medical devices ltd

Ann: Half Year Report & CEO Update, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,512 Posts.
    lightbulb Created with Sketch. 2695
    Outstanding report - with significant progress!

    Highlights:

    1. Significant advances have been made in the fundamental design and engineering based on our trial.
    2. Algorithms have made substantial progress from our learnings in the hospital
    3. Algorithms are being coded to medical device requirements by our in-house EMVision team
    4. Further patient datasets will allow continued improvements to localisation & classification of strokes
    5. Our technology continues to see strong support from stroke experts in these hospitals
    6. We are pursuing an application for the Breakthrough Device Designation program.
    7.Under the AASA program, EMV’s portable Brain Scanner offers a potentially game-changing solution
    8. Opportunity to deliver substantial savings to hospitals/healthcare system well beyond the cost of the product over its lifetime
    9. Keysight Technologies collaboration continues to progress exceptionally well
    10. Global medical imaging and device manufacturers have shown significant interest in our novel technology and its potential range of applications
    11. Interactions have been with some of the most senior executives and decision makers at these companies
    12. Our international visibility increasing
    Last edited by vintage: 25/02/21
 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.